-
Patients with certain mutations lose their walking ability earlier: Study
Specific genetic mutations in Duchenne muscular dystrophy (DMD) influence how long patients retain the ability to […]
-
Solid Biosciences Shares Updates on INSPIRE DUCHENNE Clinical Trial of SGT-003
Yesterday, Solid Biosciences shared new updates on the INSPIRE DUCHENNE clinical trial for their next-generation […]
-
REGENXBIO Shares Updates on Phase I/II AFFINITY DUCHENNE® trial of RGX-202
Yesterday, REGENXBIO shared important updates on their Phase I/II AFFINITY DUCHENNE® trial of RGX-202 for […]
-
I always try to pause to appreciate the small victories
I’m currently continuing to do the exercises my physical therapist recommended during my last therapy […]
-
Supporting artists with disabilities through a new business venture
Three weeks ago, my girlfriend, Amanda, and I embarked on a unique journey by co-founding […]
-
Sarepta Announces Discontinuation of SRP-5051 Development for Duchenne
Sarepta Therapeutics today announced that the company is discontinuing its SRP-5051 (vesleteplirsen) development program, including […]
-
WATCH: Exploring Muscle Regeneration – A New Approach with Satellos (Webinar Recording)
Satellos recently joined PPMD for a community webinar exploring a new approach for the treatment […]
-
Phase 1/2 trial of del-brax enrolling new, possibly pivotal FSHD group
A new patient group is being enrolled in a Phase 1/2 trial of delpacibart braxlosiran […]
-
As a Duchenne mom, I know I can do hard things
The seasons are changing in central Nebraska. The leaves have turned yellow and orange, a […]
-
CureDuchenne partners on World of Warcraft research fundraiser
CureDuchenne is partnering with Blizzard Entertainment, maker of the massively multiplayer online role-playing game World […]
